Stocks · Health care · Pharmaceutical Preparations

Immuneering Corp

IMRX Clue Score35
United States Fiscal year ends December CIK 0001790340 Results filed 29 Oct 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Benjamin J. Zeskind
23 Jun 2026
President and CEO
Buy
2,400
$4.56
$10.95K
Brett Matthew Hall
15 Jun 2026
Chief Scientific Officer
Buy
6,035
$4.15
$25.05K
Harold Eugene Brakewood
16 Jan 2026
Chief Business Officer
Buy
5,250
$4.76
$24.99K
Brett Matthew Hall
15 Jan 2026
Chief Scientific Officer
Buy
2,298
$4.57
$10.50K
Thomas J. Schall
15 Jan 2026
Director
Buy
21,645
$4.67
$101.04K
Leah R Neufeld
13 Jan 2026
Chief People Officer
Buy
2,626
$4.15
$10.91K
Peter Feinberg
12 Jan 2026
Director
Buy indirect
20,000
$4.35
$86.90K

What was left out

Form 4 filings counted 23
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 3,628
History held since 30 Jul 2021